Modern Pharmaceutical Law, Administration and Corporate Terms in Pharmaceutical and Healthcare Industries for Corruption-Free Circulation of Vaccines

The article considers an interdisciplinary approach to the analysis of legal, administrative and corporate mechanisms for regulating the circulation of vaccines in the pharmaceutical industry during the COVID-19 pandemic. A comprehensive study of the level of transparency of procurement, vaccine effectiveness, profitability of pharmaceutical corporations and compliance with anti-corruption legislation in the EU countries and Ukraine was conducted. Special attention is paid to the characteristics of corporate norms operating in the medical and pharmaceutical environment, their legal status, scope and significance for the formation of ethical behavior of market entities. As a result, the need for harmonization of national pharmaceutical law with European standards, development of corporate responsibility and strengthening of state and public control over the circulation of medicines and vaccines was substantiated. The study is based on the analysis of regulatory sources, official statistics, reports of international organizations, judicial precedents and examples from practice. Conclusions are drawn regarding the prospects for expanding the regulatory field and the role of corporate norms in the system of combating pharmaceutical corruption.